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In the paediatric population, oral solutions and/or suspensions represent a suitable 
alternative to preparation of hard capsules in the pharmacy. This thesis aims at 
formulation of stable liquid oral preparations with cardiologic drugs, propranol-
hydrochloride, sotalol-hydrochloride and furosemide, for the children aged from 
newborn to approximately 6 year. At the formulation of the preparation compositions, 
the simple routine preparation in a pharmacy was the main target as well as the use of 
excipients safe for paediatric population in the minimal necessary amount. 
Using a high performance liquid chromatography, chemical stability of the active 
ingredient and, simultaneously, the preservative was determined in all formulated 
preparations stored at two different temperatures at time points over minimum 180 
days. In order to achieve this, the specific analytical methods were developed and 
validated at the department of Analytical chemistry, Faculty of Pharmacy in Hradec 
Králové. However, the samples were examinated visually and the pH value was 
measured. At least 95 % of the initial drug as well as 90% of the preservative 
concentrations (100 %) remaining at the end of the stability study period were required. 
Based on the experimental results, the optimal composition of eleven multidose  
paediatric oral solutions containing and propranol-hydrochloride, sotalol-
hydrochloride, and furosemide, respectively, and a preservative for the 
extemporaneous preparation were proposed, including the storage conditions, a 
suitable container and the shelf-life. The efficacy of the antimicrobial preservative 
(Ph.Eur., 5.1.3) for the chosen preparations was demonstrated by an accredited 
laboratory. 
 
